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Background: Both intramedullary nails and sliding hip screws are used with good results in the treatment of intertro-
chanteric and subtrochanteric fractures. The aim of our study was to assess whether use of the TRIGEN INTERTAN nail, as
compared with a sliding hip screw, resulted in less postoperative pain, improved functional mobility, and reduced surgical
complication rates for patients with an intertrochanteric or subtrochanteric fracture.
Methods: In a prospective, randomized multicenter study, 684 elderly patients were treated with the INTERTAN nail or
with a sliding hip screw with or without a trochanteric stabilizing plate. The patients were assessed during their hospital
stay and at three and twelve months postoperatively. A visual analogue scale (VAS) pain score was recorded at all time
points, and functional mobility was assessed with use of the timed Up & Go test. The Harris hip score (HHS) was used to
assess hip function more speciﬁcally. Quality of life was measured with the EuroQol-5D (EQ-5D). Radiographic ﬁndings as
well as intraoperative and postoperative complications were recorded and analyzed.
Results: Patients treatedwith an INTERTANnail had slightly less pain at the time of early postoperativemobilization (VAS score,
48 versus 52; p = 0.042), although this did not inﬂuence the length of the hospital stay and there was no difference at three or
twelvemonths.Regardlessof the fracture and implant type, functionalmobility, hip function, patient satisfaction, andquality-of-life
assessments were comparable between the groups at three and twelve months. The numbers of patients with surgical compli-
cations were similar for the two groups (twenty-nine in the sliding-hip-screw group and thirty-two in the INTERTAN group, p= 0.67).
Conclusions: INTERTAN nails and sliding hip screws are similar in terms of pain, function, and reoperation rates twelve
months after treatment of intertrochanteric and subtrochanteric fractures.
Level of Evidence: Therapeutic Level I. See Instruction for Authors for a complete description of levels of evidence.
B
oth intramedullary and extramedullary implants are
currently used in the treatment of intertrochanteric and
subtrochanteric fractures. The sliding hip screw remains
the best documented implant, and in several randomized trials
it has been associated with lower complication and reoperation
rates compared with intramedullary nails1-3. In addition, the
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sliding hip screw is a less expensive implant. Nevertheless, there
has been a recent trend toward more widespread use of intra-
medullary nails for these fractures4,5, even though documen-
tation to support this change is lacking4-6.
The TRIGEN INTERTAN nail (Smith & Nephew, Mem-
phis, Tennessee) was recently introduced, and according to the
manufacturer the shape of the nail should enhance stability
and offer greater resistance to implant cutout7. Ruecker et al.8
reported good clinical results in a study on their ﬁrst 100 pa-
tients treated with an INTERTAN nail. However, we are not
aware of any study comparing the INTERTAN nail with a
sliding hip screw. The aim of the present randomized con-
trolled trial was to compare the INTERTAN nail with the
sliding hip screw, with or without a trochanteric stabilizing
plate, to determine if use of the nail decreased postoperative
pain, improved function, and lowered the surgical compli-
cation rate in elderly patients with a trochanteric or subtro-
chanteric fracture.
Materials and Methods
Patients and Fractures
Patients over sixty years of age in whom a trochanteric or subtrochantericfracture had been treated surgically at one of ﬁve hospitals from February
2008 to February 2009 were included in the study. Prior to the study, the sliding
hip screw was the favored implant for both intertrochanteric and subtro-
chanteric fractures in the participating hospitals; therefore, patients with a
subtrochanteric fracture were included. We also included cognitively impaired
patients, even if they were unable to give informed consent, a decision that was
supported by our ethical committee. Cognitive impairment was categorized by
the surgeons as ‘‘no,’’ ‘‘yes,’’ or ‘‘uncertain.’’ If there was any doubt, the clock-
drawing test
9
was used to determine the cognitive status of the patient. Patients
with a pathologic fracture were excluded. Fractures were classiﬁed by an in-
dependent radiologist according to the AO/OTA classiﬁcation
10
. Fractures distal
to, but with the main fracture line within 5 cm from, the lesser trochanter
were classiﬁed as subtrochanteric.
The inclusion of 684 patients (341 treated with an INTERTAN nail
and 343, with a sliding hip screw) is described in the CONSORT ﬂow dia-
gram
11
(Fig. 1). Two patients received the incorrect implant after allocation
in error, in four patients the stabilization choice was changed during surgery,
and six patients were not operated on according to the randomization code
for unknown reasons. According to the intention-to-treat principle, these
twelve patients remained in the group to which they had been originally
allocated.
Implants
A short or long version of the INTERTAN nail with distal locking was used
with two integrated screws inserted into the femoral head-neck fragment
(see Appendix). The nail design was described in detail by Ruecker et al.
8
.
Two different sliding hip screw implants were used (see Appendix): the
Compression Hip Screw (Smith & Nephew), and the Dynamic Hip Screw
(Synthes, Basel, Switzerland). A trochanteric stabilizing plate, either as an
integrated part of the sliding hip screw or added as a separate device onto
the sliding hip screw, was used when indicated (see Appendix). A trochanteric
stabilizing plate is indicated for all transverse or reverse oblique (A3) fractures
to prevent excessive medialization of the femoral shaft. A trochanteric sta-
bilizing plate can be considered for A1 or A2 fractures in osteoporotic bone,
where it supports a weak lateral trochanteric wall susceptible to breakage after
weight-bearing. A pilot study was performed in each hospital before patients
were enrolled in the study, and the surgeons participated in at least ﬁve
operations involving use of the INTERTAN nail before they could participate
in the study.
Follow-up
All general and fracture-related intraoperative and postoperative complications
were recorded, as were the surgeons’ level of experience, the duration of the
surgery, the patient’s hemoglobin level, the number of blood transfusions, and
the length of the hospital stay. Whenever possible, the patients were examined
on the ﬁfth postoperative day. However, some patients left the hospital before
day 5, and performing day-5 examinations during weekends was not always
possible. The time distribution of the postoperative examinations is presented in
the Appendix. Clinical examination, radiographs, and completion of a EuroQol-
5D (EQ-5D) questionnaire
12
were scheduled at three and twelve months. If pa-
tients were too frail or sick to return for follow-up, the EQ-5D questionnaire was
sent to them. A returned questionnaire, radiographs, or attendance at the out-
patient clinics was each considered acceptable follow-up. Depending on local
preferences, the clinical examination of the patients was carried out through
collaboration among a physician, a physiotherapist, and a study nurse.
Postoperative pain was our primary outcome measure. The results of
the timed Up & Go test
13
, the length of the hospital stay, the complication and
reoperation rates, and all other variables were deﬁned as secondary outcomes.
On day 5 and later follow-up intervals, the patients indicated the pain from the
treated hip on a visual analogue scale (VAS) ranging from 0 to 100, with 0
meaning no pain and 100 meaning unbearable pain. Pain at rest and at mo-
bilization was recorded in the hospital, whereas the average pain from the
operatively treated hip during the previous month was recorded at three and
twelve months. In the timed Up & Go test, the patient rises from a chair with
armrests, walks 3 m, turns around, walks back, and sits down again. Walking
aids are allowed while the patient performs the test, but active assistance is not.
The time needed for this exercise (the score for the timed Up & Go test) is the
outcome. VAS pain scores and timed Up & Go test results were measured at all
follow-up visits.
Additional secondary outcomes were the patients’ residence, walking
ability, Harris hip score (HHS), quality of life (EQ-5D score), and mortality.
Failure of the osteosynthesis, including poor initial reduction and implant
positioning, deep infection or postoperative hematoma requiring surgical in-
tervention, cutout, femoral fracture, and removal or planned removal of whole
implants were considered ‘‘major’’ complications and reoperations. Locking
screwsmissing the nail or removal of a single locking or lag screw were classiﬁed
as ‘‘minor’’ complications and reoperations in the INTERTAN group. In the
sliding-hip-screw group, surgical removal of a drain was considered a minor
reoperation and all other reoperations were considered major.
As described by Baumgaertner et al., all postoperative radiographs were
assessed for the quality of the fracture reduction (good, acceptable, or poor)
14
and the implant position in the femoral head (tip-apex distance [TAD])
15
. In
addition, shortening and medialization of the femoral shaft, changes in the
femoral neck-shaft angle, and fracture-healing were recorded.
Sample Size
A difference in VAS scores of ‡10 points was considered a clinically relevant
difference
16
. Sixty-three patients were required in each group to have an 80%
chance of detecting such a difference in VAS scores with a 5% signiﬁcance level
with an assumed standard deviation (SD) of 20. To detect a reduction in the
length of stay of one day (SD, 3), 142 patients would be needed in each group. A
difference in reoperation rates of 5% versus 7% would require 2313 patients in
each group to detect a signiﬁcant difference (with 80% power and p < 0.05).
Accordingly, although reoperation rates are of major interest in hip fracture
surgery, it was not realistic to design this trial with this as a primary outcome. A
high mortality rate, a high number of cognitively impaired patients, and an
expected high dropout rate were considered when the sample size for the study
was determined. Thus, assuming a one-year attrition rate of up to 40%, we
aimed to recruit at least 500 patients.
Randomization Procedure
Sealed, opaque, and consecutively numbered envelopes were used to randomly
allocate the patients to receive one of the two implants. Block randomization
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with varying block sizes unknown to the surgeon was used to ensure nearly
equal treatment numbers within each hospital.
Statistical Analysis
To test for group differences, the chi-square test was used for categorical variables and
the independent t test, for continuous variables. P values of <0.05 were considered
signiﬁcant (two-sided tests). The results were analyzed according to the intention-to-
treat principle. Linear regression analyses of pain and timedUp&Go test results were
performed with adjustment for the rate of cognitive impairment and the surgeons’
experience, and we also analyzed these outcomes after excluding the cognitively
impaired patients. The in-hospital pain and timed Up & Go test results were also
analyzed with adjustment for differences in the time of examination.
The Regional Committee of Ethics inWestern Norway (203.07) approved
the study, and the ClinicalTrials.gov registration number is NCT00621088.
Source of Funding
Smith & Nephew supported the study, but otherwise the company had no
inﬂuence on the study protocol, performance of the study, data analysis, or
Fig. 1
CONSORT ﬂow diagram of patients and outcome analyses11. SHS = sliding hip screw. TUG = timed Up & Go.
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presentation of the results. The ﬁrst author (K.M.) received a research grant
from the Regional Health Board of Western Norway.
Results
The baseline characteristics of the two treatment groupsare presented in Table I. More patients in the INTER-
TAN group were rated as cognitively impaired (31% versus
21%, p = 0.002) and accordingly more lived in nursing
homes (p = 0.02). There was also a tendency toward more
experienced surgeons implanting INTERTAN nails (p =
0.02).
The pain scores and timed Up & Go test results are
presented in Table II. During the initial hospitalization, there
was a minor but signiﬁcant difference in pain at the time of
postoperative mobilization in favor of the INTERTAN group
(VAS score, 48 versus 52, p = 0.042). However, this difference
was no longer evident at later follow-up times: at three and
twelve months, both groups had pain scores of 25 and 17,
TABLE I Baseline Characteristics
INTERTAN* Sliding Hip Screw* P Value†
No. of patients
Total (n = 684) 341 343
Diakonhjemmet Hospital (n = 182) 92 90
Levanger Hospital (n = 36) 18 18
Akershus University Hospital (n = 171) 83 88
Vestfold Hospital (n = 133) 68 65
Haukeland University Hospital (n = 162) 80 82
Mean age (yr) (n = 684) 84.1 84.1 0.98‡
Female (n = 684) 258 (75.7%) 255 (74.3%) 0.69§
ASA class# (n = 670) 0.56§
1 22 (6.6%) 15 (4.5%)
2 138 (41.2%) 143 (42.7%)
3 164 (49.0%) 162 (48.4%)
4 11 (3.3%) 15 (4.5%)
Cognitive impairment (n = 665) 0.002§
Yes 105 (31.3%) 68 (20.6%)
No 192 (57.3%) 231 (70.0%)
Uncertain 38 (11.3%) 31 (9.4%)
Preoperative residential status (n = 669) 0.02§
Home 208 (62.1%) 230 (68.9%)
Nursing home 94 (28.1%) 62 (18.6%)
Other 33 (9.9%) 42 (12.6%)
Mean preop. HHS** (n = 646) 68 69 0.44‡
Fracture AO/OTA type (n = 684) 0.93§
A1 150 140
A2 113 122
A3 71 68
Subtrochanteric 7 13 0.22§
Fracture on right side (n = 684) 186 (54.5%) 174 (50.7%) 0.32§
Preop. mobility (n = 650) 0.41§
Walking outdoors alone 186 (58.1%) 198 (60.0%)
Walking outdoors with living support 24 (7.5%) 31 (9.4%)
Walking indoors alone, not outdoors 79 (24.7%) 77 (23.3%)
Walking indoors with living support 26 (8.1%) 23 (7.0%)
No walking ability 5 (1.6%) 1 (0.3%)
*The values are given as the number of patients with the percentage in parentheses unless otherwise indicated.†Signiﬁcant p values are in bold.
‡Independent samples t test. §Pearson chi-square test. #American Society of Anesthesiologists classiﬁcation of comorbidities. **Harris hip
score (modiﬁed, with no value for range of movement [maximum, 5 points]).
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respectively. We found no signiﬁcant difference in the timed Up
& Go test score between the groups postoperatively or at three
or twelve months, and the rate of patients who were able to
perform the test was the same in the two groups. The lengths of
the hospital stays were also similar (see Appendix). In the linear
regression analyses, with adjustment for cognitive impairment
and surgeons’ experience, the results regarding pain, the timed
Up & Go test, and the length of stay remained unchanged.
These results also persisted in the analyses based on the actual
implants that the patients received as well as after exclusion of
the twelve patients who, according to the allocation at baseline,
received the ‘‘incorrect’’ treatment. No signiﬁcant differences in
pain or the timedUp&Go test results between the two treatment
groups were found in separate analyses of the A3 and subtro-
chanteric fractures.
Operative details and early postoperative results are sum-
marized in the Appendix. There was no signiﬁcant difference in
the operating time between the groups. Themean estimated blood
loss was greater in the sliding-hip-screw group (263 mL versus
183 mL, p < 0.001), and more patients treated with a sliding hip
screw had a blood transfusion (171 [52%] versus 143 [43%], p =
0.02). However, the lowestmeasured hemoglobin value during the
hospital stay was almost identical in the two groups.
At three and twelve months, we found no signiﬁcant
difference in the HHS or quality of life (EQ-5D score). These
results were also reﬂected by similar rates of patients regaining
their prefracture mobility and residential status.
Surgical complications and reoperations are presented
in Table III. More intraoperative technical or implant-related
problems were reported in the INTERTAN group compared
with the sliding-hip-screw group (sixty-two [19%] of 328
versus twenty-one [7%] of 315, p < 0.001). However, the
majority were minor problems without consequence for the
patients. We found no difference regarding in-hospital general
medical complications. At twelve months, twenty-eight and
twenty-seven patients had had a reoperation in the INTERTAN
and sliding-hip-screw groups, respectively. Five postopera-
tive femoral fractures occurred in the INTERTAN group, all
during the ﬁrst three months; one fracture was at the distal
tip of a long nail, and the other fractures appeared around the
tips of short nails. One fracture occurred through the distal
screw hole in a four-hole sliding hip screw-plate (see Ap-
pendix). The difference between the groups was not signiﬁcant
(p = 0.10). Cutouts of implants were observed in twenty-four
patients (3.5%), eleven in the sliding-hip-screw group and
thirteen in the INTERTAN group (p = 0.67) (see Appendix).
However, not all cutouts led to revision surgery, which was
performed for nine of the eleven sliding-hip-screw cutouts and
six of the thirteen INTERTAN-nail cutouts. Subgroup analyses of
A3 and subtrochanteric fractures showed no signiﬁcant differ-
ence in complication and reoperation rates between the groups.
Details of the radiographic assessments are described in
the Appendix. The quality of the reduction was similar for the
two groups, but the postoperative femoral neck-shaft angle
demonstrated more varus in the INTERTAN group (131
versus 138, p < 0.001). Accordingly, lag screws for INTERTAN
nails were more frequently positioned in the superior part of
the femoral head. Furthermore, the intramedullary nails were
TABLE II Primary Outcomes
INTERTAN Sliding Hip Screw
Mean Difference
(95% Conﬁdence
Interval) P Value*
Mean VAS score for pain
Postop.
At rest 22 (n = 283) 21 (n = 289) 1.1 (22.3-4.5) 0.54†
At mobilization 48 (n = 269) 52 (n = 284) 23.7 (27.4-0.04) 0.042†
3 mo 25 (n = 226) 25 (n = 206) 20.5 (24.6-3.6) 0.82
12 mo 17 (n = 185) 17 (n = 192) 0.05 (24.0-4.1) 0.98
Timed Up & Go test
Postop. (no. [%] of patients)
Total no. assessed 306/341 295/343 0.14
Unable to perform test 167 (55%) 163 (55%) 0.87
Test performed, not passed‡ 7 (2%) 6 (2%) 0.83
Test performed and passed‡ 132 (43%) 126 (43%) 0.92
Mean score (sec)
Postop. 74 (n = 132) 69 (n = 126) 5.1 (23.5-14.3) 0.20†
3 mo 29 (n = 177) 29 (n = 164) 0.04 (24.3-4.4) 0.99
12 mo 27 (n = 154) 25 (n = 160) 1.3 (23.6-6.2) 0.60
*Signiﬁcant p value is in bold.†Adjusted p values; adjustments were made because of differences in the time distribution of patient examinations.
The unadjusted p value for pain at mobilization was 0.053. ‡A timed Up & Go test of more than three minutes and thirty seconds was considered
to be a test not passed.
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associated with more initial shortening than the sliding hip
screws, and this difference persisted at one year. Femoral shaft
medialization of >5 mm at one year was more frequent in the
sliding-hip-screw group. The number of patients with mediali-
zation of >5mm at twelve months also depended on the fracture
type (5.2% for A1, 11.4% for A2, and 22.3% for A3), and pa-
tients with >5 mm of medialization had more postoperative
pain compared with those with <5 mm of medialization (VAS
score, 23 and 16, respectively). The timed Up & Go test results,
however, were independent of medialization. Within the sliding-
hip-screw group, twelve of the fourteen fractures with >10 mm
of medialization had been treated with a trochanteric stabiliz-
ing plate. The average TAD was shorter and more favorable
in the INTERTAN group (18 mm versus 21 mm, p < 0.001).
The average TAD for all patients who had an implant cutout
was 26 mm, whereas the average for those without a cutout
was 20 mm (p < 0.001). Similarly, a poor reduction and a
lower femoral neck-shaft angle were associated with more
surgical complications. Poorly reduced fractures were as-
sociated with an 18% complication rate, whereas those with
a good reduction were associated with a 7% complication
rate (p = 0.007). Patients with complications also had a lower
postoperative femoral neck-shaft angle compared with those
without surgical complications (132 and 135, respectively;
p = 0.038).
Mortality
The one-year mortality rate was approximately 25% for the
INTERTAN and sliding-hip-screw groups (24.6% and 25.4%,
respectively; p = 0.83).
Discussion
Overall, we found comparable results between patientstreated with the INTERTAN intramedullary nail and those
TABLE III Intraoperative, Early, and Late Postoperative Complications and Reoperations in the Two Treatment Groups
INTERTAN* (N = 341) Sliding Hip Screw* (N = 343) P Value†
Intraop. complications
Technical or implant-related (n = 643)‡ 62/328 (18.9%) 21/315 (6.7%) <0.001
Requiring surgical intervention§ 4 2 0.41
Other in-hospital complications
General medical 104 110 0.79
Early postop. death 8 14 0.20
Postop. surgical complications
(including those with nonop. treatment)#
32 (9.4%) 29 (8.5%) 0.67
Major 26 (7.6%) 27 (7.9%) 0.90
Minor 7 (2.1%) 2 (0.6%) 0.09
Reoperation in 1st 12 mo 28 (8.2%) 27 (7.9%) 0.87
Indications for reoperations
Major reoperations** 23 (6.7%) 28 (8.2%) 0.48
Cutout 6 (1.8%) 9 (2.6%)
Infection 2 (0.6%) 3 (0.9%)
Fracture around implant 5 (1.5%) 1 (0.3%)
Mechanical failure/nonunion 3 (0.9%) 10 (2.9%)
Poor reduction/implant position 4 (1.2%) 3 (0.9%)
Other 3 (0.9%) 2 (0.6%)
Minor reoperations 5 (1.5%) 1 (0.3%) 0.10
Removal of drain 1
Adding distal locking screw 3
Removal of distal locking screw 1
Removal of separate lag screw 1
1-yr mortality†† 24.6% 25.4% 0.83
*The values are given as the number of patients with the percentage in parentheses unless otherwise indicated. †Pearson chi-square test. The
signiﬁcant p value is in bold. ‡Technical or implant-related problems were mainly minor problems without any crucial inﬂuence on the surgical
procedure or the outcome of the operation. Exceptions are listed in the row below. §One femoral fracture after nailing was treated with a long
INTERTAN nail as planned. One long nail was converted to a short nail because of distal anterior cortex penetration. Two planned long nails were
converted to a short nail because of a short femur in one case and a narrow femur in the other. One intraoperative ﬁssure with a sliding hip screw was
treated with a longer plate. Another intraoperative fracture/ﬁssure with a sliding hip screw was not detected initially and was treated with a reoperation
eleven days later.#More than one complication per patient is possible. Seven patients in the INTERTAN group and two patients in the sliding-hip-screw
group with a cutout left surgically untreated are included. **More than one reason per patient possible. ††Kaplan-Meier survival analyses.
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treated with the sliding hip screw. The INTERTAN group had
less pain at the time of early postoperative mobilization, but this
difference was not reﬂected in better functional mobility or a
shorter hospital stay and may not be clinically important. No
differences in pain, function, quality of life, or complication rates
were evident at three or twelve months postoperatively. This
ﬁnding is in agreement with those of most recent studies and
meta-analyses1,6,17-19.
For an individual patient, a VAS pain-score difference of
10 points is considered clinically relevant16. Although this may
be interpreted differently at a group level, a difference of 4 points
in the early postoperative phase, as was found in the present
study, is probably of minor clinical relevance. The mean es-
timated blood loss was 80 mL higher in the sliding-hip-screw
group, but assessing ‘‘internal’’ blood loss after nailing is difﬁcult.
More patients in the sliding-hip-screw group received a blood
transfusion, but we had no protocol for when to perform
transfusions, and the hemoglobin level at the time of trans-
fusion was not known. The differences in blood loss and in
the number of blood transfusions did not seem to inﬂuence the
length of hospital stay or in-hospital complication rates. There-
fore, the clinical relevance of these differences is unclear.
The timed Up & Go test13 and the HHS20 are outcome
measures commonly used to assess function after hip frac-
tures21. Regardless of the functional outcome measure used in
the present study, we did not detect any signiﬁcant difference
between the two implant groups during follow-up, which is in
agreement with the ﬁndings of recent meta-analyses1,2,22.
Since the introduction of nailing for intertrochanteric
fractures, peri-implant femoral fractures have been well-known
complications23-26. According to Bhandari et al.19, this should no
longer be an issue with modern nail designs and more expe-
rience; however, the authors of a Cochrane review1 came to a
different conclusion. In our study, two intraoperative and ﬁve
postoperative femoral fractures occurred in the INTERTAN
group, all within the ﬁrst three months. In another recent study
using INTERTAN nails, a 6% rate of postoperative femoral
fractures was reported27. This implies that the problem with
fractures around the tips of intramedullary nails has not been
completely solved.
To date, no consistent difference in implant-cutout rates
has been found between intramedullary nails and sliding hip
screws in randomized trials1. In a prospective study on patients
treated with the INTERTAN nail, Ruecker et al.8 reported two
implant cutouts in forty-eight patients with one year of follow-
up. In the present study, implant cutout was the most common
cause of failure of the osteosynthesis, but we found no signif-
icant difference between the treatment groups.
Treating unstable reverse oblique and subtrochanteric
fractures with a sliding hip screw is controversial, and is not
recommended by many authors6,28-30. However, in our view, the
scientiﬁc evidence fromwell-designed clinical studies supporting
the exclusive use of intramedullary nails in this subgroup of
fractures is lacking. Recent meta-analyses also demonstrated that
more high-quality studies are required before deﬁnitive conclu-
sions regarding implant selection for these fractures can be
drawn1,29,31. We have continued to favor the use of the sliding
hip screw for these fractures, but we are using an additional
trochanteric stabilizing plate to prevent excessive medialization
of the femoral shaft.
It is well known that poor reduction and implant posi-
tion result in a poor prognosis in hip fracture treatment16,32-35.
In the present study, implant cutout and other surgical com-
plications were associated with a higher TAD, poor reduction,
or reduction more into varus but were independent of the type
of implant. Therefore, an increased focus on surgical perfec-
tion, rather than implant selection, is probably the best way to
address this problem. Fewer patients in the INTERTAN group
had medialization exceeding 5 mm, probably because of the
intramedullary position of the nail providing solid resistance to
excessive sliding along the axis of the lag screw. The increased
medialization in the sliding-hip-screw group could not be
prevented by the trochanteric stabilizing plate, and our data do
not allow us to quantify the extent to which a trochanteric
stabilizing plate may have helped. Despite radiographic dif-
ferences in femoral neck-shaft angle, shortening, TAD, and
medialization, no difference in pain, function, or surgical com-
plication rate between the two groups was evident. Similarly,
no signiﬁcant differences in these outcomes were found in
subgroup analyses of A3 and subtrochanteric fractures. We are
not aware of any randomized controlled trial comparing the
use of a sliding hip screw (including a trochanteric stabilizing
plate) with intramedullary nailing in this speciﬁc group of
patients. Two randomized controlled trials36,37 comparing an
intramedullary nail with other extramedullary implants in
the treatment of A3 fractures were, however, reported in the
Cochrane Database Review1. One study demonstrated a higher
reoperation rate for patients treated with a Dynamic Condylar
Screw (DCS) compared with the Proximal Femoral Nail (PFN)36,
whereas one study comparing a blade plate with a gamma nail
revealed no difference in reoperation rates37. These studies,
however, included only small numbers of patients (thirty-nine
and twenty-six, respectively). Contradictory ﬁndings were also
reported for patients with subtrochanteric fractures when either a
95 blade plate38 or the Medoff sliding plate39,40 was compared
with an intramedullary nail. In our trial, the sliding hip screw
(including a trochanteric stabilizing plate) appeared to be a
valid option for treatment of these fractures.
A major strength of the present study is the number of
patients included. To our knowledge, this is the largest pub-
lished series of its kind. In addition, due to its multicenter
design, many different surgeons and several hospitals partici-
pated in the study, closely resembling a real-life setting.
There are some limitations to our study. Preoperatively,
some potential risk factors for a poor outcome could have been
assessed with more detail. Still, American Society of Anesthe-
siologists (ASA) class, preoperative mobility, quality of life
(EQ-5D score), preoperative health status, and HHS were re-
corded as baseline characteristics. In addition, the randomi-
zation and large number of patients included should reduce the
risk of any selection bias and the risk of baseline differences
between the two groups.
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Cognitively impaired patients were included in our study.
It might be difﬁcult to obtain accurate information regarding
pain from such patients, whomay also ﬁnd it difﬁcult to perform
functional tests. Nevertheless, many patients with a hip fracture
are cognitively impaired, and we found it important to include
this group of patients. Despite the randomization, rates of de-
mentia differed slightly between the groups. We sought to min-
imize this problem by adjusting for differences between the
groups. Analyses performed with the cognitively impaired pa-
tients excluded provided similar results.
We were not able to examine all patients on the same
postoperative day, and this could potentially have biased our
results. However, for this reason, a linear regression analysis
with adjustment for differences in the time distribution of
postoperative examinations was performed, and the timing
of the postoperative evaluations did not inﬂuence our results
signiﬁcantly.
The higher number of experienced surgeons performing
the operations with the INTERTAN nails was a concern, but the
overall percentage of consultants operating on patients in our
study was low (11%). In addition, regression analyses adjusting
for the surgeons’ formal qualiﬁcations did not inﬂuence our
results. Finally, the lack of blinding of patients and examiners
may have potentially inﬂuenced our ﬁndings. However, in this
multicenter study involving large numbers of patients, physi-
cians, and other research personnel in ﬁve hospitals with a
duration of follow-up of one year, we considered blinding the
patients (and examiners) with respect to the treatment to be
too ambitious, if possible at all.
Our long-term follow-up rate was 79% of those still alive at
one year, which is less than desirable. Still, with the large number
of patients included and with no difference in follow-up rates
between the groups, we believe that our main ﬁndings are valid.
In conclusion, we found similar results regarding pain,
function, complications, and reoperation rates at one year in
this randomized controlled trial comparing the INTERTAN
nail and the sliding hip screw for the treatment of intertro-
chanteric and subtrochanteric fractures. Patients treated with
the INTERTAN nail had slightly less pain at the time of initial
postoperative mobilization and received fewer blood transfu-
sions. However, this did not inﬂuence the length of the hospital
stay, function, or complication rate.
Improving outcomes and reducing complication rates
after treatment of these fractures remain a challenge, but to
achieve a good outcome, optimizing hip fracture reduction
and implant position is probably more important than the
choice of implant.
Appendix
Tables showing operative and postoperative data and
radiographic ﬁndings as well as ﬁgures demonstrating
INTERTAN nails, sliding hip screws, the trochanteric stabi-
lizing plate, the time distribution of the evaluations for early
postoperative pain and performance of the timed Up & Go
test, postoperative femoral fractures, and cutout are avail-
able with the online version of this article as a data supple-
ment at jbjs.org. n
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Fig. E1-A  
The INTERTAN nail was short or long. 
 
 
 
 
Fig. E1-B 
The sliding hip screw comes in different lengths, and is used with or without a trochanteric 
stabilizing plate. 
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Fig. E1-C 
The trochanteric stabilizing plate was either an integrated part of the sliding hip screw or a separate 
plate added onto the sliding hip screw. 
 
 
 
Fig. E2 
Time distribution of the evaluations for early postoperative pain and performance of the timed Up & 
Go test. Sixty-nine patients were not evaluated either with the timed Up and Go test or with the VAS 
pain scores. SHS = sliding-hip-screw group. 
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Fig. E3-A         Fig. E3-B 
Figs. E3-A and E3-B Postoperative femoral fractures included one femoral fracture in the sliding-hip-
screw group and five fractures in the INTERTAN group (four associated with short nails and one 
associated with a long nail). Fig. E3-A A sliding hip screw with a periprosthetic fracture at the level of 
the distal screw. Fig. E3-B A short INTERTAN nail with a periprosthetic fracture at the tip of the nail. 
 
 
 
     
Fig. E4-A     Fig. E4-B          Fig. E4-C 
Figs. E4-A, E4-B, and E4-C There were thirteen cases of cutout/cut-through in the INTERTAN group 
and eleven cases of cutout in the sliding-hip-screw group. Fig. E4-A A short INTERTAN nail with 
cutout in the femoral head. Fig. E4-B A short INTERTAN nail with cutout in the femoral head and 
migration of the proximal lag screw into the acetabulum. Fig. E4-C A sliding hip screw with a cutout in 
the femoral head. 
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TABLE E-1 Operative and Postoperative Data in the Two Treatment Groups* 
 INTERTAN* (N = 341) 
Sliding Hip Screw* (N = 
343) P Value† 
Op. data    
Preop. delay (n = 666)   0.65‡ 
<24 hr 181 (54.0%) 167 (50.5%)  
24-48 hr 109 (32.5%) 116 (35.0%)  
>48 hr 45 (13.4%) 48 (14.5%)  
Anesthesia (n = 667)   0.82‡ 
Spinal 304 (90.7%) 303 (91.3%)  
General 31 (9.3%) 29 (8.7%)  
Surgeon’s experience (n = 664)   Á 
Resident <2 yr 70 (21.4%) 101 (30.0%)  
Resident >2 yr 183 (56.0%) 184 (54.6%) 
Resident assisted by consultant 34 (10.4%) 20 (5.9%) 
Consultant 40 (12.2%) 32 (9.5%) 
Duration of surgery (n = 661) (min)    
All fractures 54.7 (n = 331) 55.6 (n = 330) 0.69§ 
AO/OTA type A1 46.1 (n = 145) 44.0 (n = 133) 0.39§ 
AO/OTA type A2 57.1 (n = 112) 54.4 (n = 118) 0.44§ 
AO/OTA type A3 and 
subtrochanteric 
67.8 (n = 74) 76.5 (n = 79) 0.10§ 
Long nail or sliding hip screw 
w/trochanteric stabilizing plate# 
   
AO/OTA type A1 8/149 (5%) 9/141 (6%)  
AO/OTA type A2 38/113 (34%) 39/122 (32%)  
AO/OTA type A3 44/70 (63%) 51/69 (74%)  
Subtrochanteric 7/7 (100%) 6/13 (46%)  
Total** 97/339 (29%) 105/345 (30%)  
Postop. data    
Transfusion (n = 663) 143 (43.1%) 171 (51.7%) Á 
Mean est. external blood loss (n = 
650) (mL) 
183 263  
Mean hemoglobin value (g/dL)    
Preop. (n = 660)  12.1 12.0 0.81§ 
Lowest postop. (n = 650) 9.2 9.1 0.26§ 
Mean length of postop. hospital stay 
(n = 684) (days) 
8.5  8.4  0.85§ 
Residence after discharge (n = 650)   0.81‡ 
Home 39 (11.9%) 47 (14.6%)  
Nursing home 190 (57.9%) 168 (52.2%)  
Rehab. 47 (14.3%) 47 (14.6%)  
Other 52 (15.9%) 60 (18.6%)  
*The values are given as the number of patients with the percentage in parentheses unless otherwise indicated. †Significant p 
values are in bold. ‡Pearson chi-square test. §Independent samples t test. #The use of different implants was based on the fracture 
classification and degree of osteoporosis. All hospitals received a guide describing when to use long nails or an additional 
trochanteric stabilizing plate, but this decision was finally left to the surgeon. **The actual implants used were not identical with 
the randomization code for twelve of the 684 patients (Fig. 1). Therefore, the numbers are slightly different compared with other 
(intention-to-treat) analyses. 
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TABLE E-2 Radiographic Findings 
 INTERTAN* Sliding Hip Screw* P Value† 
Postop. fracture reduction‡   0.25§ 
Good 147 (44%) 164 (48%)  
Acceptable 141 (43%) 143 (42%) 
Poor 44 (13%) 32 (9%)  
Total 332 (100%) 339 (100%)  
Shortening at 12 mo    
None 88 (49%) 111 (61%)  
<10 mm 71 (39%) 47 (26%) 
10-20 mm 11 (6%) 19 (11%) 
>20 mm 10 (6%) 4 (2%) 
Total 180 (100%) 181 (100%) 
Medialization at 12 mo   
<5 mm 153 (85%) 127 (71%)  
5-10 mm 18 (10%) 23 (13%) 
10 mm 9 (5%) 28 (16%)  
Total 180 (100%) 178 (100%)  
Radiographic fracture-
healing at 12 mo 
  0.80§ 
Yes 154 (86%) 158 (87%)  
No 13 (7%) 14 (8%) 
Uncertain 13 (7%) 10 (6%) 
Mean postop. tip-apex 
distance (TAD)# (n = 655) 
(mm) 
18 21  
Mean femoral neck-shaft 
angle (deg) 
  
Postop. (n = 678) 131 138  
12 mo (n = 361) 126 132  
*The values are given as the number of patients with the percentage in parentheses unless otherwise indicated. †Significant p 
values are in bold. ‡The postoperative reduction was considered “good” with no more than 4 mm of displacement of any fracture 
fragment and normal or slight valgus alignment on the anteroposterior radiograph, and <20° of angulation on the lateral 
radiograph. Fractures that had either good alignment or no more than 4 mm of displacement, but not both, were rated as 
“acceptable.” Fractures that fulfilled neither criterion were categorized as “poor.” §Pearson chi-square test. #TAD = the sum of 
the distance from the (superior) lag screw to the apex of the femoral head on the frontal and lateral view, adjusted for 
magnification. **Independent samples t test. 
 
